{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:50:06Z","timestamp":1778759406884,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12032-013-0492-0","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T11:58:38Z","timestamp":1360583918000},"source":"Crossref","is-referenced-by-count":23,"title":["Clinical features and outcome of patients with HIV-negative multicentric Castleman\u2019s disease treated with combination chemotherapy: a report on 10 patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Shou-Hui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"492_CR1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822\u201330.","journal-title":"Cancer"},{"key":"492_CR2","unstructured":"Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In: Clark RL, Cumley RW editor. Chicago: Year Book Medical Publishers; 1970. p. 296\u20139."},{"key":"492_CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670\u201383.","journal-title":"Cancer"},{"key":"492_CR4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99:2331\u20136.","journal-title":"Blood"},{"key":"492_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI26190","volume":"116","author":"FD Fakhari","year":"2006","unstructured":"Fakhari FD, Jeong JH, Kanan Y, Dittmer DP. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Invest. 2006;116:735\u201342.","journal-title":"J Clin Invest"},{"key":"492_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000325316","volume":"53","author":"A Nanda","year":"2009","unstructured":"Nanda A, Handa U, Punia RS, Mohan H. Fine needle aspiration in retroperitoneal Castleman\u2019s disease: a case report. Acta Cytol. 2009;53:316\u20138.","journal-title":"Acta Cytol"},{"key":"492_CR7","first-page":"486","volume":"8","author":"F Rhee van","year":"2010","unstructured":"van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010;8:486\u201398.","journal-title":"Clin Adv Hematol Oncol"},{"key":"492_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ajcp\/69.1.86","volume":"69","author":"AR Gaba","year":"1978","unstructured":"Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69:86\u201390.","journal-title":"Am J Clin Pathol"},{"key":"492_CR9","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","volume":"93","author":"Y Aoki","year":"1999","unstructured":"Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, Tosato G. Angiogenesis and hematopoiesis induced by Kaposi\u2019s sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999;93:4034\u201343.","journal-title":"Blood"},{"key":"492_CR10","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1046\/j.1523-1755.2000.00422.x","volume":"58","author":"YG Kim","year":"2000","unstructured":"Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int. 2000;58:2390\u20139.","journal-title":"Kidney Int"},{"key":"492_CR11","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1053\/j.ajkd.2003.09.023","volume":"43","author":"A Seida","year":"2004","unstructured":"Seida A, Wada J, Morita Y, Baba M, Eguchi J, Nishimoto N, et al. Multicentric Castleman\u2019s disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury? Am J Kidney Dis. 2004;43:E3\u20139.","journal-title":"Am J Kidney Dis"},{"key":"492_CR12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1634\/theoncologist.2011-0075","volume":"16","author":"N Talat","year":"2011","unstructured":"Talat N, Schulte KM. Castleman\u2019s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16:1316\u201324.","journal-title":"Oncologist"},{"key":"492_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-5-7","volume":"5","author":"IA Vries de","year":"2010","unstructured":"de Vries IA, van Acht MM, Demeyere T, Lybeert ML, de Zoete JP, Nieuwenhuijzen GA. Neoadjuvant radiotherapy of primary irresectable unicentric Castleman\u2019s disease: a case report and review of the literature. Radiat Oncol. 2010;5:7.","journal-title":"Radiat Oncol"},{"key":"492_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0305-7372(95)90034-9","volume":"21","author":"MJ McCarty","year":"1995","unstructured":"McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman\u2019s disease). Cancer Treat Rev. 1995;21:291\u2013310.","journal-title":"Cancer Treat Rev"},{"key":"492_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05311.x","volume":"129","author":"C Casper","year":"2005","unstructured":"Casper C. The aetiology and management of Castleman disease at 50\u00a0years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3\u201317.","journal-title":"Br J Haematol"},{"key":"492_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3960\/jslrt.48.39","volume":"48","author":"M Kojima","year":"2008","unstructured":"Kojima M, Shimizu K, Ikota H, Ohno Y, Motoori T, Itoh H, et al. \u201cFollicular variant\u201d of hyaline-vascular type of Castleman\u2019s disease: histopathological and immunohistochemical study of 11 cases. J Clin Exp Hematop. 2008;48:39\u201345.","journal-title":"J Clin Exp Hematop"},{"key":"492_CR17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAP.0b013e3181a9d4d3","volume":"16","author":"DM Cronin","year":"2009","unstructured":"Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236\u201346.","journal-title":"Adv Anat Pathol"},{"key":"492_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2559.1994.tb00552.x","volume":"24","author":"DT Nguyen","year":"1994","unstructured":"Nguyen DT, Diamond LW, Hansmann ML, Alavaikko MJ, Schr\u00f6der H, Fellbaum C, et al. Castleman\u2019s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology. 1994;24:437\u201343.","journal-title":"Histopathology"},{"key":"492_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01607150","volume":"423","author":"AD Danon","year":"1993","unstructured":"Danon AD, Krishnan J, Frizzera G. Morpho-immunophenotypic diversity of Castleman\u2019s disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Virchows Arch A Pathol Anat Histopathol. 1993;423:369\u201382.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"492_CR20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00000478-199711000-00004","volume":"21","author":"O Lin","year":"1997","unstructured":"Lin O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman\u2019s disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol. 1997;21:1295\u2013306.","journal-title":"Am J Surg Pathol"},{"key":"492_CR21","first-page":"1211","volume":"38","author":"SP Murphy","year":"1997","unstructured":"Murphy SP, Nathan MA, Karwal MW. FDG-PET appearance of pelvic Castleman\u2019s disease. J Nucl Med. 1997;38:1211\u20132.","journal-title":"J Nucl Med"},{"key":"492_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1157\/13097380","volume":"26","author":"A Iagaru","year":"2007","unstructured":"Iagaru A, Mari C, Sam Gambhir S. Follicular dendritic sarcoma within a focus of Castleman\u2019s disease. Serial FDG PET\/CT in the follow up of recurrence with histopathologic confirmation. Rev Esp Med Nucl. 2007;26:40\u20135.","journal-title":"Rev Esp Med Nucl"},{"key":"492_CR23","first-page":"142","volume":"31","author":"U Elboga","year":"2012","unstructured":"Elboga U, Narin Y, Urhan M, Sahin E. FDG PET\/CT appearance of multicentric Castleman\u2019s disease mimicking lymphoma. Rev Esp Med Nucl Imagen Mol. 2012;31:142\u20134.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"492_CR24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4065\/70.10.969","volume":"70","author":"H Shahidi","year":"1995","unstructured":"Shahidi H, Myers JL, Kvale PA. Castleman\u2019s disease. Mayo Clin Proc. 1995;70:969\u201377.","journal-title":"Mayo Clin Proc"},{"key":"492_CR25","first-page":"850","volume":"112","author":"JL Seco","year":"1992","unstructured":"Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman\u2019s disease. Surgery. 1992;112:850\u20135.","journal-title":"Surgery"},{"key":"492_CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0022-3468(95)90707-6","volume":"30","author":"VJ Shroff","year":"1995","unstructured":"Shroff VJ, Gilchrist BF, DeLuca FG, McCombs HL, Wesselhoeft CW. Castleman\u2019s disease presenting as a pediatric surgical problem. J Pediatr Surg. 1995;30:745\u20137.","journal-title":"J Pediatr Surg"},{"key":"492_CR27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q","volume":"92","author":"GM Chronowski","year":"2001","unstructured":"Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92:670\u20136.","journal-title":"Cancer"},{"key":"492_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-128-8-199804150-00010","volume":"128","author":"J Herrada","year":"1998","unstructured":"Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128:657\u201362.","journal-title":"Ann Intern Med"},{"key":"492_CR29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7","volume":"85","author":"WB Bowne","year":"1999","unstructured":"Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, et al. The management of unicentric and multicentric Castleman\u2019s disease: a report of 16 cases and a review of the literature. Cancer. 1999;85:706\u201317.","journal-title":"Cancer"},{"key":"492_CR30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s12032-009-9355-0","volume":"27","author":"B Ye","year":"2010","unstructured":"Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman\u2019s disease: a report of 52 patients. Med Oncol. 2010;27:1171\u20138.","journal-title":"Med Oncol"},{"key":"492_CR31","first-page":"636","volume":"20","author":"BA Peterson","year":"1993","unstructured":"Peterson BA, Frizzera G. Multicentric Castleman\u2019s disease. Semin Oncol. 1993;20:636\u201347.","journal-title":"Semin Oncol"},{"key":"492_CR32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","volume":"3","author":"G Frizzera","year":"1985","unstructured":"Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3:1202\u201316.","journal-title":"J Clin Oncol"},{"key":"492_CR33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOH.0b013e328186ffab","volume":"14","author":"A Dham","year":"2007","unstructured":"Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354\u20139.","journal-title":"Curr Opin Hematol"},{"key":"492_CR34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2169\/internalmedicine.42.182","volume":"42","author":"K Iyonaga","year":"2003","unstructured":"Iyonaga K, Ichikado K, Muranaka H, Fujii K, Yamaguchi T, Suga M. Multicentric Castleman\u2019s disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide. Intern Med. 2003;42:182\u20136.","journal-title":"Intern Med"},{"key":"492_CR35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0360-3016(78)90019-6","volume":"4","author":"DG Nordstrom","year":"1978","unstructured":"Nordstrom DG, Tewfik HH, Latourette HB. Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy. Int J Radiat Oncol Biol Phys. 1978;4:1045\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"492_CR36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4","volume":"44","author":"DD Weisenburger","year":"1979","unstructured":"Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer. 1979;44:457\u201362.","journal-title":"Cancer"},{"key":"492_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1258\/095646206775220496","volume":"17","author":"LS Collins","year":"2006","unstructured":"Collins LS, Fowler A, Tong CY, de Ruiter A. Multicentric Castleman\u2019s disease in HIV infection. Int J STD AIDS. 2006;17:19\u201324.","journal-title":"Int J STD AIDS"},{"key":"492_CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CCO.0b013e328349c233","volume":"23","author":"D Reddy","year":"2011","unstructured":"Reddy D, Mitsuyasu R. HIV-associated multicentric Castleman disease. Curr Opin Oncol. 2011;23:475\u201381.","journal-title":"Curr Opin Oncol"},{"key":"492_CR39","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12032-011-9886-z","volume":"29","author":"H Alkaied","year":"2012","unstructured":"Alkaied H, Harris K, Elsayegh D, Khachaturova I, Awasum M, Varma S. Does Kaposi\u2019s sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy? Med Oncol. 2012;29:1109\u201313.","journal-title":"Med Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0492-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T04:47:01Z","timestamp":1595393221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0492-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]},"article-number":"492"}}